Abstract
Get full access to this article
View all access options for this article.
References
1.Bangladesh Expert Committee for Drugs (1982 ) Evaluation of Registered/Licensed Products and Draft National Drug Policy. Report, 11 May 1982; page 93 .
2.Government of Bangladesh (1982 ) Drugs (Control) Ordinance (No. viii). Government of the People's Republic of Bangladesh, 12 June 1982.
3.
Mahler
H
(1982 ) Keynote address to Eleventh IFPMA Assembly, Washington, DC. IFPMA, Nordstrasse 15, POB 328, CH-8035, Zurich.
4.Office of Health Economics (1982 ) Medicines, Health and the Poor World. OHE, 12 Whitehall, London SW1A 2DY; pp 29 –31 .
5.
Peretz
S M
(1981 ) Pharmacy International (February)
2 , viii –xii .
6.World Health Organization (1982 ) Action Programme on Essential Drugs. Thirty-Fifth World Health Assembly, 1 April 1982. WHO Document A35/7.
7.
Woriock
A
(1982 ) Pharmaceuticals in Developing Countries . Proceedings of Eleventh IFPMA Assembly, Washington, DC. IFPMA, Nordstrasse 15, POB 328, CH-8035, Zurich.